Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0284
Bid: 0.03
Ask: 0.031
Change: 0.0029 (11.37%)
Spread: 0.001 (3.333%)
Open: 0.025
High: 0.04
Low: 0.025
Prev. Close: 0.0255
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Executive Board Appointments

13 Aug 2021 07:00

RNS Number : 5737I
Supply @ME Capital PLC
13 August 2021
 

13 August 2021

Supply@ME Capital plc

(The "Company" or "SYME")

 

Thomas James and John Collis appointed as SYME Executive Directors

 

Following the recent successful completion of the acquisition of TradeFlow Capital Management Pte Ltd. ("TradeFlow"), and the Company's 2020 Annual General Meeting held on 30 July 2021, Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation© service to manufacturing and trading companies, is pleased to confirm the appointments of Dr Thomas James and Mr John Collis to the Board of the Company as Executive Directors.

 

Dr James and Mr Collis will continue in their current executive roles, leading the TradeFlow business.

 

The following information is disclosed pursuant to the QCA Corporate Governance Code and best practice:

 

Thomas Glyn James (Tom James) (aged 49) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Skybird Records Ltd.

Navitas Resources Capital Ltd

Commodity Partners International Ltd.

TradeFlow Capital Management Systems Pte Ltd

Tijara Pte Ltd

Navitas Resources (UK) Ltd. (Dormant)

Navitas Resources Pte Ltd. (Dormant)

 

Dr. James currently holds 406,500,000 Ordinary shares in the Company.

 

John Charles Collis (aged 51) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Kenwood Secretaries Ltd

International Knowledge Ltd

TradeFlow Capital Management Systems Pte Ltd

Navitas Resources Capital Ltd

Tijara Pte Ltd

Kenwood Nominees Ltd

JCS 110 Ltd

Higher Education Research Ltd

English Pocket Opera Company

MTI Solutions Ltd

JCS 105 Ltd

Ultraponix Ltd

Price Verifier System Ltd

SoftNPower Ltd

JCS 107 Ltd

 

 

 

Mr Collis currently holds 406,500,000 Ordinary shares in the Company.

 

There is no further information on either Director to be disclosed pursuant to The LSE Standard Listing Rulebook.

 

Notes

Supply@ME enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which the business intends to sell to the end-customers or goods/ commodities part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables strong companies to improve their working capital cycle. The funds do not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGUGDILXBDGBX
Date   Source Headline
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants
2nd May 202312:00 pmRNSSYME moves to SETS trading platform
28th Apr 20232:51 pmRNS2022 Annual Report and Accounts and Financing
26th Apr 20237:00 amRNSCommitment for first IM from traditional funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.